Biểu đồ giá cổ phiếu NVO
NVO Thu nhập
Novo Nordisk A/S
$46.4
0.71%
$0.32
Khi đóng cửa: May 11, 16:00:00 GMT-4
$47.54
2.45%
$1.14
Phiên trước giờ: May 12, 06:13:16 GMT-4
Quay lại
Novo Nordisk A/S (NVO) Thu nhập
Thống kê chính
Giá đóng cửa trước
$46.07
Giá mở cửa
$46.69
Phạm vi ngày
$46.27 - $47.79
Phạm vi 52 tuần
$35.12 - $81.44
Khối lượng
17.7M
Khối lượng trung bình
20.1M
Tỷ suất cổ tức
--
EPS (TTM)
3.60
Vốn hóa thị trường
$210.8B
Novo Nordisk A/S là gì?
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
